BAT's Sell-Off Raises Stakes for Half-Year Update as Analyst Calls Diverge

British American Tobacco closed a shortened trading week sharply lower, with the stock shedding 6.37 percent over five sessions to land at €52.66. The decline accelerated through four consecutive losing days, and Friday’s volume surged to 14.69 million shares — more than six times the previous day’s 2.12 million. The move had no obvious fundamental catalyst, suggesting a technical correction within an otherwise intact uptrend that still shows gains of 9.37 percent year-to-date and 33.15 percent over the past twelve months.

Even as the market pushed the shares lower, a pair of heavyweight investment banks reiterated bullish stances. UBS reaffirmed its buy recommendation on Friday with a price target of 5,750 pence, implying upside of roughly 25 percent from the current level. Barclays chimed in earlier in the week, lifting its target from 4,900 to 5,400 pence and maintaining an “Overweight” rating. Those calls sit at opposite ends of a wide analyst spectrum: the consensus from six analysts stands near 4,708 pence, while the gap between the most optimistic and most pessimistic forecasts exceeds 2,300 pence.

The divergence in sentiment is sharpened by the timing. Tuesday’s half-year trading update, due at 7 a.m. British time, will test whether the optimists or the reality of recent price action has the better read on BAT’s trajectory. Hargreaves Lansdown’s head of analysis, Derren Nathan, has noted that the group entered the year guiding toward the lower end of its medium-term targets — 3 to 5 percent revenue growth and 4 to 6 percent operating profit expansion. Investors will be watching for confirmation that pricing power in combustibles remains intact and that the “New Categories” (vaping and heated tobacco) are gaining enough traction to offset the decline in traditional cigarettes.

Should investors sell immediately? Or is it worth buying British American Tobacco?

On the technical side, the sell-off has brought the stock closer to key support. The zone between €50.89 and €51.64 is reinforced by multiple trendlines and moving averages, with the 50-day simple moving average currently at €51.38 serving as the first meaningful floor. A break below that level would deepen the correction, while a bounce could set the stage for a recovery toward the May 18 high of €57.18, with the next resistance at €57.48. The stock, however, remains above its 50-, 100- and 200-day averages, suggesting the long-term trend has not yet been broken.

Chief Executive Tadeu Marroco added a small but symbolic signal of alignment last week, acquiring 173 shares through a dividend reinvestment plan at £43.72 each, for a total of £7,563. The purchase came as the shares were already sliding, and while the amount is modest, it aligns with the broader narrative of management confidence.

The debt trajectory will also be under scrutiny. Investors expect net debt to move back toward the target range of 2.0 to 2.5 times operating cash flow, a key prerequisite for sustaining the share buyback programme and a dividend yield north of 5 percent. Those capital-return attractions remain powerful — but only if the underlying growth story does not disappoint further.

Tuesday’s update will therefore go a long way toward determining whether the banks’ bullish price targets or the market’s recent caution has the better claim on BAT’s near-term direction. With a wide dispersion of analyst views and a sharp technical sell-off, the stakes could hardly be higher.

Ad

British American Tobacco Stock: New Analysis - 31 May

Fresh British American Tobacco information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated British American Tobacco analysis...

en | GB0002875804 | BATS | boerse | 69451274 |